novel AAV-based therapies for retinal disease

By Anonymous (not verified) , 20 August, 2026
ID
30
Pathway
Entrepreneurship, Biomedical Design, and Innovation
Description
UMass Chan researchers have developed two novel retinotopic capsids capable of widespread targeting of retinal cells through a less invasive delivery route.
Goals
identify specific inherited monogenic retinal diseases that are most amenable to this technology; Conduct outreach to relevant
faculty and patients to better understand workflow, unmet needs, and adoption barriers;
Mentor
Ozge Yildiz
Mentor E-mail
Ozge.Yildiz@umassmed.edu
Department
BRIDGE
Prior Students
Angie Zhu, Jared Gao, Julian Gonzales
Availability
Yes
Number Spots
3